CRESCITA THERAPEUTICS INC (CTX.CA) Stock Income Statement
TSX:CTX - CA2258471028 - Common Stock
0.46 CAD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.27M | 19.58M | 17.52M | 23.53M | 16.77M | |||
| Cost Of Goods | 9.73M | 9.97M | 7.16M | 10.34M | 7.08M | |||
| Gross Profit | 10.53M | 9.61M | 10.36M | 13.18M | 9.69M | |||
| Operating Expenses | 12.55M | 12.82M | 12.32M | 12.65M | 11.52M | |||
| Research and Development | 585.00K | 646.00K | 699.00K | 610.00K | 630.00K | |||
| Selling, General, and Administrative Expenses | 10.48M | 10.81M | 9.16M | 9.62M | 8.56M | |||
| Operating Income | -2.02M | -3.21M | -1.96M | 530.00K | -1.83M | |||
| Interest Income/Expense | 578.00K | 343.00K | 448.00K | -10.00K | -290.00K | |||
| Other Income/Expense | 91.00K | 108.00K | -22.00K | -120.00K | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 1.11M | |||
| Income Before Taxes | -1.35M | -2.76M | -1.53M | 400.00K | -1.01M | |||
| Income Tax | N/A | -14.00K | 456.00K | -460.00K | 100.00K | |||
| Net Income | -1.33M | -2.75M | -1.99M | 860.00K | -1.11M | |||
| EBITDA | -632.00K | -1.85M | -450.00K | 2.00M | -450.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.07 | -0.14 | -0.10 | 0.04 | -0.05 | |||
| Statistics | ||||||||
| Gross Profit Margin | 51.98% | 49.07% | 59.15% | 56.01% | 57.78% | |||
| Profit Margin | -6.57% | -14.04% | -11.33% | 3.65% | -6.62% | |||
| Operating Profit Margin | -9.94% | -16.42% | -11.16% | 2.25% | -10.91% | |||
All data in CAD